- Home
- TBBK vs ACLX Comparison
TBBK vs ACLX Comparison
Compare TBBK & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBBK
- ACLX
- Stock Information
- Founded
- TBBK 1999
- ACLX 2015
- Country
- TBBK United States
- ACLX United States
- Employees
- TBBK N/A
- ACLX N/A
- Industry
- TBBK Major Banks
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- TBBK Finance
- ACLX Health Care
- Exchange
- TBBK Nasdaq
- ACLX Nasdaq
- Market Cap
- TBBK 3.5B
- ACLX 4.1B
- IPO Year
- TBBK 2004
- ACLX 2022
- Fundamental
- Price
- TBBK $79.60
- ACLX $79.98
- Analyst Decision
- TBBK Buy
- ACLX Strong Buy
- Analyst Count
- TBBK 4
- ACLX 12
- Target Price
- TBBK $68.00
- ACLX $114.75
- AVG Volume (30 Days)
- TBBK 643.0K
- ACLX 510.9K
- Earning Date
- TBBK 10-23-2025
- ACLX 11-06-2025
- Dividend Yield
- TBBK N/A
- ACLX N/A
- EPS Growth
- TBBK 21.62
- ACLX N/A
- EPS
- TBBK 4.65
- ACLX N/A
- Revenue
- TBBK $515,889,000.00
- ACLX $56,979,000.00
- Revenue This Year
- TBBK N/A
- ACLX N/A
- Revenue Next Year
- TBBK $7.02
- ACLX $210.71
- P/E Ratio
- TBBK $17.11
- ACLX N/A
- Revenue Growth
- TBBK 11.18
- ACLX N/A
- 52 Week Low
- TBBK $40.51
- ACLX $47.86
- 52 Week High
- TBBK $80.19
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- TBBK 71.11
- ACLX 67.86
- Support Level
- TBBK $74.68
- ACLX $73.16
- Resistance Level
- TBBK $77.25
- ACLX $78.61
- Average True Range (ATR)
- TBBK 2.23
- ACLX 2.92
- MACD
- TBBK -0.16
- ACLX 0.70
- Stochastic Oscillator
- TBBK 90.18
- ACLX 99.12
About TBBK The Bancorp Inc
The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, specialty finance (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Specialty finance includes REBL (real estate bridge lending) comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.
About ACLX Arcellx Inc.
Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.